Product Reports Resources Pricing Login Book a demo

MileBot Robotics

Robotics · Shenzhen, China · Founded 2016

Shenzhen based Robotics company MoreLess

Founded in 2016, MileBot Robotics is a medical robotics company specializing in the development of exoskeleton robots for rehabilitation. The company was established by a team of PhDs with overseas experience in robotic rehabilitation technologies, including CEO Chen Gong, CTO Ye Jing, and COO Hu Feng. Chen Gong holds a PhD in Biomedical Engineering from the National University of Singapore, while Ye Jing earned a PhD in Biotechnology (Robotics) from Waseda University in Japan. Their collective expertise in robotics, human-computer interaction, and rehabilitation medicine forms the company's technical foundation.

MileBot Robotics operates in the medical rehabilitation market, serving clients such as hospitals, community health centers, and disability federations. The company's business model is centered on the sale of its robotic products and collaboration with institutions to enhance service quality and product performance. The firm has secured multiple rounds of funding, with notable investors including Lenovo Group and WEGO Group. Milestones include receiving angel funding in 2017, initiating clinical trials in 2019, and obtaining NMPA product registration in 2021 before starting a large-scale international expansion in 2024.

The company's product line focuses on lower limb rehabilitation, featuring a core technology of compliant actuators for safer human-robot interaction. Products include the BEAR series for adult lower limb rehabilitation, the RELAX series for pediatric patients, and the MAX Gait Assist Systems. These devices offer various training modes, from passive to active-assisted, and integrate with a Health Care Cloud Platform that uses IoT and big data for remote monitoring and assessment. The robots are designed to assist patients who have experienced strokes, spinal cord injuries, or brain injuries by providing targeted gait training. A key feature of some models is the inclusion of six powered joints, which allows for more natural and flexible movement during therapy.

Keywords: exoskeleton robotics, medical rehabilitation, lower limb rehabilitation, gait training, human-computer interaction, compliant actuators, assistive technology, neurorehabilitation, physical therapy robotics, stroke recovery, spinal cord injury recovery, wearable robotics, medical devices, rehabilitation engineering, robotic therapy, mobility assistance, pediatric rehabilitation, intelligent rehabilitation systems, healthcare robotics, gait assist

Talent graph

MileBot Robotics's talent

Book a demo to see the people
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on MileBot Robotics's cap table

Sourced from Dealroom's funding and investor records.

Seed 1 investor entered at this stage
Share Capital
Series A 2 investors entered at this stage
Lenovo
Shangyuan Capital
Series B+ 1 investor entered at this stage
CSC Financial

Global footprint

Where MileBot Robotics has talent and traffic

Workforce by country
🇨🇳 China · Shenzhen HQ
Book a demo for the full country breakdown

Market sentiment

What the market is saying about MileBot Robotics

An AI-synthesized read of the highest-engagement posts about MileBot Robotics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MileBot Robotics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.